Export 5 results:
Author Title Type [ Year(Desc)]
Filters: Author is Mutua, Gaudensia  [Clear All Filters]
2009
E. Karita, Ketter, N., Price, M. A., Kayitenkore, K., Kaleebu, P., Nanvubya, A., Anzala, O., Jaoko, W., Mutua, G., Ruzagira, E., Mulenga, J., Sanders, E. J., Mwangome, M., Allen, S., Bwanika, A., Bahemuka, U., Awuondo, K., Omosa, G., Farah, B., Amornkul, P., Birungi, J., Yates, S., Stoll-Johnson, L., Gilmour, J., Stevens, G., Shutes, E., Manigart, O., Hughes, P., Dally, L., Scott, J., Stevens, W., Fast, P., and Kamali, A., “CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.”, PLoS One, vol. 4, no. 2, p. e4401, 2009.
2012
G. Mutua, Sanders, E., Mugo, P., Anzala, O., Haberer, J. E., Bangsberg, D., Barin, B., Rooney, J. F., Mark, D., Chetty, P., Fast, P., and Priddy, F. H., “Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.”, PLoS One, vol. 7, no. 4, p. e33103, 2012.
2014
G. Omosa-Manyonyi, Park, H., Mutua, G., Farah, B., Bergin, P. J., Laufer, D., Lehrman, J., Chinyenze, K., Barin, B., Fast, P., Gilmour, J., and Anzala, O., “Acceptability and feasibility of repeated mucosal specimen collection in clinical trial participants in Kenya.”, PLoS One, vol. 9, no. 10, p. e110228, 2014.
2015
P. Mwangi Mugo, Sanders, E. J., Mutua, G., van der Elst, E., Anzala, O., Barin, B., Bangsberg, D. R., Priddy, F. H., and Haberer, J. E., “Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.”, AIDS Behav, vol. 19, no. 5, pp. 794-801, 2015.
2016
G. Mutua, Farah, B., Langat, R., Indangasi, J., Ogola, S., Onsembe, B., Kopycinski, J. T., Hayes, P., Borthwick, N. J., Ashraf, A., Dally, L., Barin, B., Tillander, A., Gilmour, J., De Bont, J., Crook, A., Hannaman, D., Cox, J. H., Anzala, O., Fast, P. E., Reilly, M., Chinyenze, K., Jaoko, W., Hanke, T., and Group, T. Hiv- Core 0, “Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.”, Mol Ther Methods Clin Dev, vol. 3, p. 16061, 2016.